Parsifal Capital Management, LP In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Parsifal Capital Management, LP reported 16 stock positions worth $1.1 billion . Its top holding was Avepoint (AVPT) at 11.9% of the portfolio, followed by Albertsons Cos Class A (ACI, 10.9% ) and Sharkninja (SN, 10.4% ). Compared with Q2 2025, it opened 5 new positions, sold out of 2, added to 4 and reduced 7. The biggest buy was a new position in Sensient Technologies (SXT) and the biggest sale an exit from Nutanix Class A (NTNX).
Location GREENWICH, CT
CIK 0001776090
Portfolio Value $1.1B (Q3 2025) Holdings 16 stocks · $1.1B Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2025 AVPT Avepoint Inc. 8,522,740 $127.9M Add +61.2% ACI Albertsons Cos Inc. Class A 6,709,248 $117.5M Reduce -5.3% SN Sharkninja Inc. 1,083,600 $111.8M Add +2.1% DLTR Dollar Tree Inc. 1,052,185 $99.3M Reduce -22.4% HGV Hilton Grand Vacations Inc. 2,197,280 $91.9M Reduce -11.8% MMM 3M Co. 583,858 $90.6M Reduce -18.0% GXO Gxo Logistics Inc. 1,482,957 $78.4M Add +77.5% GMED Globus Medical Inc. Class A 1,104,332 $63.2M Add +29.5% ATMU Atmus Filtration Technologie 1,243,020 $56.0M Reduce -28.6% UNH Unitedhealth Group Inc. 154,600 $53.4M Reduce -16.5% SXT Sensient Technologies Corp. 498,500 $46.8M New LPX Louisiana-Pacific Corp. 519,600 $46.2M New TEVA Teva Pharmaceutical-SP ADR 2,010,507 $40.6M Reduce -30.7% IESC Ies Holdings Inc. filed as IES HLDGS INC 64,800 $25.8M New CVS CVS Health Corp. 182,300 $13.7M New HUM Humana Inc. 44,000 $11.4M New
Portfolio Sells Q2 2025 → Q3 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▲ NTNX Nutanix Inc. Class A Sold out 0.00% −5.44 ACI Albertsons Cos Inc. Class A Reduce -5.3% 10.93% −3.58 DLTR Dollar Tree Inc. Reduce -22.4% 9.24% −3.56 CORZ Core Scientific Inc. Sold out 0.00% −2.46 MMM 3M Co. Reduce -18.0% 8.43% −1.90 HGV Hilton Grand Vacations Inc. Reduce -11.8% 8.55% −1.31 TEVA Teva Pharmaceutical-SP ADR Reduce -30.7% 3.78% −0.85 ATMU Atmus Filtration Technologie Reduce -28.6% 5.22% −0.82 UNH Unitedhealth Group Inc. Reduce -16.5% 4.97% −0.53
Portfolio Buys Q2 2025 → Q3 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▼ SXT Sensient Technologies Corp. New 4.35% +4.35 LPX Louisiana-Pacific Corp. New 4.30% +4.30 GXO Gxo Logistics Inc. Add +77.5% 7.30% +3.42 IESC Ies Holdings Inc. New 2.40% +2.40 AVPT Avepoint Inc. Add +61.2% 11.90% +2.18 CVS CVS Health Corp. New 1.28% +1.28 GMED Globus Medical Inc. Class A Add +29.5% 5.89% +1.09 HUM Humana Inc. New 1.07% +1.07 SN Sharkninja Inc. Add +2.1% 10.40% +0.39
Options Activity Q2 2025 → Q3 2025 Security Type Change vs Q2 2025 Underlying Shares Value ▼ SN Sharkninja Inc. put Sold out 1,061,300 $105.1Mbefore exit CORZ Core Scientific Inc. put Sold out 1,514,600 $25.9Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 14 $816.5M COMP, HGV, SN, AXTA, AKAM Q1 2026 17 $774.6M COMP, HGV, SN, AKAM, AXTA Q4 2025 15 $992.6M SN, HGV, GMED, TEVA, GXO Q3 2025 16 $1.1B AVPT, ACI, SN, DLTR, HGV Q2 2025 13 $1.0B ACI, DLTR, MMM, SN, HGV Q1 2025 15 $956.2M ACI, HGV, MMM, SN, AVPT Q4 2024 16 $1.2B ACI, HGV, SN, MMM, CLX Q3 2024 14 $1.3B ACI, SN, HGV, CLX, TEVA Q2 2024 18 $1.4B SN, HGV, ACI, CLX, TEVA Q1 2024 19 $1.4B SN, HGV, ACI, CLX, BRSL